Is Zscaler Stock a Buy After Its Share Price Plummets?

Zscaler posted solid fiscal Q3 results with revenue up 25% year over year to $850.5 million and adjusted EPS of $1.08, both ahead of guidance, but management's cautious outlook disappointed investors. Q4 revenue guidance of $875 million to $878 million and fiscal 2027 ARR growth of 16% to 17% came in below expectations, with the company citing sales leadership changes and difficulty adding new customers. The stock fell more than 30% on the report and is now down about 50% over the past year.

Analysis

The market is not punishing the quarter; it is repricing the durability of the growth engine. When a security platform starts leaning harder on expansion revenue and financing gimmicks while new-logo conversion softens, the multiple compression is usually a forward signal that sales efficiency has deteriorated before it shows up in the income statement. The two sales-exec departures matter less as personnel risk than as evidence that the go-to-market motion may be losing repeatability right when the company needs to defend premium valuation.

Second-order, the stronger mix from existing customers and AI-driven attach is a double-edged positive: it improves near-term retention, but it can mask a weakening top-of-funnel until the budget cycle rolls over. If Red Canary is outperforming while core growth slows, investors should assume the acquisition is acting as a growth offset rather than an accelerator, which limits margin for error over the next 2-3 quarters. That makes the next catalyst path asymmetric: any further softness in new ARR or billings will likely force additional multiple compression before fundamentals stabilize.

The contrarian angle is that the selloff probably overshot on near-term optics but may still be underpricing the time needed to repair the sales machine. At ~5x forward sales, the stock is no longer expensive, but cheap on a “good business with a temporary issue” basis only if new-customer conversion inflects within one or two quarters. If it does not, this becomes a dead-money setup rather than a value opportunity, because retention alone rarely re-rates a platform name without reaccelerating net-new demand.

Key Decisions for Investors

• Avoid initiating a fresh long in ZS for now; wait 1-2 quarters for evidence that new-logo ARR stabilizes before considering entry. Risk/reward is poor if the stock remains range-bound while fundamentals repair.
• For holders, sell covered calls 1-2 quarters out to monetize elevated implied volatility and offset downside from further guidance resets. This fits a 'dead-money with event risk' profile.
• Pair trade: long higher-quality cybersecurity names with clearer new-business momentum versus short ZS on a 3-6 month horizon. The thesis is multiple dispersion driven by sales execution, not sector demand collapse.
• If ZS drops another 10-15% without a corresponding cut to FY2027 ARR assumptions, consider a tactical starter long with a tight stop, as the market may have over-discounted the sales leadership transition.
• Watch next-quarter new customer adds and billings more than EPS; if those re-accelerate, the stock can re-rate 15-25% quickly, but if they miss again the valuation floor likely shifts lower.